October 23, 2026- SEKISUI Diagnostics has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&B in professional healthcare settings. The OSOM® COVID-19/Flu A&B Combo Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab specimens from individuals with signs and symptoms of respiratory tract infection. CLIA-waived for point-of-care use, the OSOM COVID-19/Flu A&B Combo Test is manufactured in the USA and backed by an experienced technical services team of medical laboratory professionals.
The OSOM COVID-19/Flu A&B Combo Test includes QC Inside®, a unique feature which maximizes the value of every kit by eliminating separate Quality Control (QC) costs and provides two additional patient tests for external QC at no charge.